FDA approves Moderna's new lower-dose COVID-19 vaccine
The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company's existing shot, but a second option.
The new vaccine, mNexspike, is a step toward next-generation coronavirus vaccines. It's made in a way that allows for a lower dose — a fifth of the dose of its current COVID-19 vaccine, Spikevax — by refining its immune target.
The approval 'adds an important new tool to help protect people at high risk of severe disease from COVID-19,' Stephane Bancel, Moderna's CEO, said in a statement Saturday.
The Food and Drug Administration approved the new vaccine for use in all adults 65 and older, and for people age 12 to 64 who have a least one health condition that puts them at increased risk from the coronavirus.
That's the same limit that the FDA set in licensing another COVID-19 vaccine option from competitor Novavax.
Those restrictions are a departure from how the U.S. has handled COVID-19 vaccines until now, reflecting skepticism about vaccines from Health Secretary Robert F. Kennedy Jr. and other Trump officials.
Moderna's existing vaccine doesn't face those limits and has long been used for anyone ages 6 months and older. The company said it expected to offer both options this fall.
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective — and more by some measures — than the original shot, the company said.
The news came just days after the Trump administration canceled funding for Moderna to develop a vaccine against potential pandemic flu viruses, including the H5N1 bird flu, despite promising early study results.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
9 minutes ago
- The Guardian
White House insists Trump tariffs to stay despite court ruling
Update: Date: 2025-06-02T09:46:32.000Z Title: White House: Tariffs to stay despite legal setback Content: Hello and welcome to the US politics live blog. I'm Tom Ambrose and I will be bringing you the latest news lines over the next few hours. We start with news that president Trump's top economic advisers have said they would not be deterred by a court ruling that declared many of the administration's tariffs illegal. They cited other legal options the White House could use to pressure China and other countries into trade talks. They also indicated that Trump had no plans to extend a 90-day pause on some of the highest tariffs, making it more likely those duties will take effect in July. 'Rest assured, tariffs are not going away,' Commerce Secretary Howard Lutnick said on Fox News Sunday. Asked about the future of the suspended reciprocal tariffs first announced in April, Lutnick added: 'I don't see today that an extension is coming.' It comes as China accused the US of 'seriously violating' the fragile US-China detente that has been in place for less than a month since the two countries agreed to pause the trade war that risked upending the global economy. China and the US agreed on 12 May to pause for 90 days the skyrocketing 'reciprocal' tariffs that both countries had placed on the others goods in a frenzied trade war that started a few weeks earlier. Tariffs had reached 125% on each side, which officials feared amounted to virtual embargo on trade between the world's two biggest economies. In other news: The US veterans agency has ordered scientists not to publish in journals without clearance. The edict, laid down in emails on Friday by Curt Cashour, the VA's assistant secretary for public and intergovernmental affairs, and John Bartrum, a senior adviser to VA secretary Doug Collins, came hours after the article published in the New England Journal of Medicine. Russell Vought, the director of the office of management and budget (OMB), on Sunday cast doubt on the constitutional obligation of the White House to ask Congress to sign off on Donald Trump's massive cuts to the federal workforce spearheaded by Elon Musk. Vought indicated the White House preferred to rely on 'executive tools' for all but a 'necessary' fraction of the cuts instead of submitting the whole package of jobs and agency slashing that took place via the so-called 'department of government efficiency' (Doge), to the congressional branch for its official approval. The US Department of Homeland Security (DHS) removed a list of 'sanctuary' states, cities and counties from its website following sharp criticism from a sheriffs' association that said a list of 'noncompliant' sheriffs could severely damage the relationship between the Trump administration and law enforcement. The White House budget director Russ Vought on Sunday dismissed as 'totally ridiculous' fears expressed by voters that cuts to benefits in the huge spending bill passed by the House will lead to premature deaths in America. Donald Trump's One Big Beautiful Bill Act, now awaiting debate in the US Senate, will slash two major federal safety net programs, Medicaid, which provides healthcare to poor and disabled Americans, and the Supplemental Nutrition Assistance Program (Snap), which helps people afford groceries, which will affect millions of people if it becomes law.
Times
10 minutes ago
- Times
China warns Britain over Royal Navy aircraft carrier in east Asia
Act now to keep your subscription We've tried to contact you several times as we haven't been able to take payment. You must update your payment details via My Account or by clicking update payment details to keep your subscription.
The Independent
21 minutes ago
- The Independent
Pakistan's anti-polio drive suffers a blow after a northern enclave reports first case in 7 years
Pakistan efforts to eliminate polio suffered another blow on Monday after a northern enclave reported its first case in seven years. Overall, it was the country's 11th case since January, despite the launch of several immunization drives. The virus was detected in a child from the district of Diamer in the Gilgit-Baltistan region, according to the country's polio eradication program. Pakistan and neighboring Afghanistan remain the only two countries where the spread of the wild polio virus has not been stopped, according to the World Health Organization. There are ongoing outbreaks of polio linked to the oral vaccine in 10 other countries, mostly in Africa. The new case was reported after Pakistan on Sunday wrapped up its third nationwide polio vaccination drive of the year, aiming to immunize 45 million children. Mohammad Iqbal, a director at the polio program in the northwest, said local health officials were still trying to determine how the poliovirus that was found in the southern port city of Karachi had infected the child in Diamer. During the summer season, thousands of tourists from Karachi and elsewhere visit tourist resorts in Gilgit-Baltistan. Pakistan's polio eradication program has been running anti-polio campaigns for years, though health workers and the police assigned to protect them are often targeted by militants who falsely claim the vaccination campaigns are a Western conspiracy to sterilize children. Since the 1990s, attacks on polio vaccination teams have killed more than 200 workers and security personnel.
